Study for performance evaluation of the QIAstat-Dx® BCID Plus AMR GPF-Panel and the QIAstat Dx® BCID Plus AMR GN-Panel in comparison with other chosen comparator methods
This multicenter study aims to evaluate the performance of QIAstat-Dx® BCID Plus AMR GPF-Panel and the QIAstat Dx® BCID Plus AMR GN-Panel with another validated comparator method.
Study Type
OBSERVATIONAL
Enrollment
2,142
The performance of QIAstat-Dx® BCID GN and GPF Plus AMR Panels will be evaluated in comparison with another validated comparator method, using residual specimens of positive blood culture. Pure colonies derived from the residual positive blood culture specimens will also be tested
QIAGEN
Manchester, United Kingdom
PPA
positive percentage agreement
Time frame: 6 moths
NPA
negative percentage agreement
Time frame: 6 moths
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.